Access cutting-edge opioid addiction treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Access opioid addiction specialists in Newark at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid addiction treatment provided free
This project, involving two distinct clinical trials, tests whether induction to a higher than currently recommended buprenorphine (BUP) induction dose is safe and can improve the proportion of patients who engage in comprehensive addiction services within 7-day of induction. Trial 1 is a head-to-head comparison of the safety, tolerability and feasibility of high dose BUP induction (32 mg). The study involves two cohorts, (1) a 12mg cohort (standard) to determine baseline data and (2) a 32 mg (
Sponsor: Rutgers, The State University of New Jersey
Check if you qualify for this opioid addiction clinical trial in Newark, NJ
If you're searching for opioid addiction treatment options in Newark, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid addiction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.